Adverse event reporting patterns of concomitant botanical dietary supplements with CYP3A4 interactive & CYP3A4 non-interactive anticancer drugs in the U.S. Food and Drug Administration Adverse Event Reporting System (FAERS)-Reference-Cited by-同舟云学术

Adverse event reporting patterns of concomitant botanical dietary supplements with CYP3A4 interactive & CYP3A4 non-interactive anticancer drugs in the U.S. Food and Drug Administration Adverse Event Reporting System (FAERS)

Published:2018-12-27 Issue:2 Volume:18 Page:145-152
ISSN:1474-0338
Container-title:Expert Opinion on Drug Safety
language:en
Short-container-title:Expert Opinion on Drug Safety

Author:

Fahim Shahariar Mohammed¹^ORCID,Mishuk Ahmed Ullah¹,Cheng Ning¹,Hansen Richard¹,Calderón Angela I.²,Qian Jingjing¹

Affiliation:

1. Department of Health Outcomes Research and Policy, Auburn University Harrison School of Pharmacy, Auburn, AL, USA

2. Department of Drug Discovery and Development, Auburn University Harrison School of Pharmacy, Auburn, AL, USA

Funder

Auburn University Research Initiative in Cancer

Publisher

Informa UK Limited

Subject

Pharmacology (medical),General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14740338.2019.1562546

Reference44 articles.

1. Heart Disease and Cancer Deaths — Trends and Projections in the United States, 1969–2020

2. Cancer statistics, 2018

3. Dietary Supplements Commonly Used by Cancer Survivors: Are There Any Benefits?

4. Trends in botanical dietary supplement use among US adults by cancer status: The National Health and Nutrition Examination Survey, 1999 to 2014

5. Office of Dietary Supplements. National Institutes of Health (NIH). Botanical dietary supplements. [cited 2017 Sept 22]. Available from: https://ods.od.nih.gov/factsheets/BotanicalBackground-HealthProfessional/

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Examining dietary supplements containing Euterpe oleracea Mart. (açaí) for potential botanical-drug interactions involving CYP3A4 inhibition;Phytomedicine Plus;2024-08

2. Exploring the impact of co-exposure timing on drug-drug interactions in signal detection through spontaneous reporting system databases: a scoping review;Expert Review of Clinical Pharmacology;2024-04-18

3. Standardization of açaí extracts for in-vitro assays based on anthocyanin quantitation;Journal of Food Composition and Analysis;2023-05

4. The prevalence and predictors of herb-drug interactions among Iranian cancer patients during chemotherapy courses;BMC Complementary Medicine and Therapies;2023-02-07

5. Real-world data on herb-drug interactions in oncology: A scoping review of pharmacoepidemiological studies;Phytomedicine;2022-08